These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9424884)
1. [Changes in tissue plasminogen activator in experimental peritonitis caused by pathogenic factors]. Karoń J; Zozulińska M; Grzywacz A; Pawlaczyk K; Połubińska A Wiad Lek; 1997; 50 Suppl 1 Pt 2():259-63. PubMed ID: 9424884 [TBL] [Abstract][Full Text] [Related]
2. Time course of peritoneal tissue plasminogen activator after experimental colonic surgery: effect of hyaluronan-based antiadhesive agents and bacterial peritonitis. Reijnen MM; Holmdahl L; Kooistra T; Falk P; Hendriks T; van Goor H Br J Surg; 2002 Jan; 89(1):103-9. PubMed ID: 11851673 [TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389 [TBL] [Abstract][Full Text] [Related]
4. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis. van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459 [TBL] [Abstract][Full Text] [Related]
5. Bile increases lipopolysaccharide release in experimental E. coli peritonitis. Andersson R; Sonesson A; Larsson L; Schalén C; Tranberg KG Eur J Surg; 1991 Feb; 157(2):117-20. PubMed ID: 1676304 [TBL] [Abstract][Full Text] [Related]
6. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. Klaerner HG; Uknis ME; Acton RD; Dahlberg PS; Carlone-Jambor C; Dunn DL J Surg Res; 1997 Jul; 70(2):161-5. PubMed ID: 9245566 [TBL] [Abstract][Full Text] [Related]
7. Effects of CO2 insufflation on bacterial growth in rats with Escherichia coli-induced experimental peritonitis. Sare M; Yesilada O; Gürel M; Balkaya M; Yologlu S; Fiskin K Surg Laparosc Endosc; 1997 Feb; 7(1):38-41. PubMed ID: 9116945 [TBL] [Abstract][Full Text] [Related]
8. [Resistance and changes in the biological properties of bacteria isolated from patients with peritonitis]. Lizgunova AV; Fedorov VD Antibiotiki; 1972 Feb; 17(2):166-71. PubMed ID: 4554080 [No Abstract] [Full Text] [Related]
9. Early effects of laparotomy and laparoscopy on bacterial behavior and proinflammatory cytokines on bacterial peritonitis in rats I: Escherichia coli. Didem B; Hüseyin B; Osman Y; Yasemin B; Necati G; Canan T J Pediatr Surg; 2008 Aug; 43(8):1494-501. PubMed ID: 18675641 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. van Goor H; de Graaf JS; Grond J; Sluiter WJ; van der Meer J; Bom VJ; Bleichrodt RP Br J Surg; 1994 Jul; 81(7):1046-9. PubMed ID: 7922060 [TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis. Renckens R; Roelofs JJ; Florquin S; van der Poll T J Infect Dis; 2006 Feb; 193(4):522-30. PubMed ID: 16425131 [TBL] [Abstract][Full Text] [Related]
12. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat. Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model. van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653 [TBL] [Abstract][Full Text] [Related]
14. The influence of omentectomy on bacterial clearance: an experimental study. Uzunköy A; Ozbilge H; Horoz M Ulus Travma Acil Cerrahi Derg; 2009 Nov; 15(6):541-5. PubMed ID: 20037870 [TBL] [Abstract][Full Text] [Related]
15. Absence of direct relationship between intraperitoneal cellular influx and resistance to experimental peritonitis. Van Geertruyden N; De Wilde JP; Bournonville B; Struelens M; Kinnaert P Acta Chir Belg; 1998 Aug; 98(4):148-53. PubMed ID: 9779236 [TBL] [Abstract][Full Text] [Related]
16. Bacterial peritonitis and the bursting strength of intestinal anastomoses. Kilam SK; Jackson FL; Williams HT Can J Surg; 1975 Jul; 18(4):372-5, 378. PubMed ID: 1097084 [TBL] [Abstract][Full Text] [Related]
17. Surgical trauma does not decrease resistance to infection. De Wilde JP; Lebrun E; Bournonville B; Kinnaert P Eur J Surg; 1998 May; 164(5):339-43. PubMed ID: 9667467 [TBL] [Abstract][Full Text] [Related]
18. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of the bacteria causing inflammatory-purulent complications in leukemia]. Smirnova AI; Solov'eva AI; Eremina TN; Baliubash LA Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):27-30. PubMed ID: 799789 [No Abstract] [Full Text] [Related]
20. Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection. Roelofs JJ; Rouschop KM; Teske GJ; Wagenaar GT; Claessen N; Weening JJ; van der Poll T; Florquin S Nephrol Dial Transplant; 2009 Mar; 24(3):801-8. PubMed ID: 18842674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]